Human Immunomics Initiative will decode immune system, speed new vaccines
Harvard Chan School, Human Immunomics Initiative announce project to speed vaccines.
Coronavirus (COVID-19): Press Conference with Sarah Fortune, 03/26/20
Transcript You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Sarah Fortune, the John LaPorte Given Professor and Chair of the Department of Immunology and Infectious Diseases. This call was recorded…
New center aims to advance research toward a vaccine for TB
A new NIH-funded center at Harvard Chan School aims to advance research toward a vaccine for TB.
Seeking the Path of Least Resistance
Rising antibiotic resistance is not just a medical crisis. It's a scientific, economic, political, and moral problem. Can we act before it's too late?
Is a full course of antibiotics always necessary?
Harvard Chan School experts say that while shorter courses of antibiotics may be OK in some cases, they’re not safe overall.
Study suggests antibodies may offer protection against tuberculosis
Findings open new window on the biology of the disease, offer inroads to new rapid diagnostic and vaccine approaches For immediate release: Thursday, September 22, 2016 Boston, MA – Antibodies are one of the body’s first lines of…
Researchers discuss drug resistance in reddit ‘AMA’
On Tuesday, June 28, Harvard Chan School faculty Sarah Fortune, professor of immunology and infectious diseases, and Eric Rubin, Irene Heinz Given Professor of Immunology and Infectious Diseases, discussed the growing threat of antibiotic resistance during a reddit “Ask…
‘Superbug’ found in Pennsylvania patient highlights dangers of antibiotic resistance
May 31, 2016 -- A “superbug” that is resistant to colistin—the antibiotic of last resort—was recently found in a U.S. patient with a urinary tract infection. Sarah Fortune, professor of immunology and infectious diseases at Harvard Chan School,…
Researchers optimistic about malaria vaccine progress
April 12, 2016 — While the world is as close as it has ever been to having a malaria vaccine, the fight to eradicate the disease is far from over. That was the consensus among experts in the…
In pursuit of an elusive foe
The bacteria that cause tuberculosis are experts at survival, allowing the disease to persist even when faced with the immune system and drugs. Harvard T.H. Chan School of Public Health’s Sarah Fortune is on a mission to figure out…
